Microencapsulation of sodium alendronate reduces drug mucosal damage in rats

References

• Adami, S., Passeri, M., Ortolani, S., Broggini, M., Carratelli, L., Caruso, I., Gandolini, G., Gnessi, L., Laurenzi, M., Lombardi, A., Norbiato, G., Pryortillotson, S., Reda, C., Romanini, L., Subrizi, D., Wei, L., Yates, A.J. (1995). Effects of oral alendronate and intranasal salmon-calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis. Bone. 17:383–90.
   PubMed Web of Science ®Google Scholar
• Al Deeb, S.K., Hamdan, I.I., Al Najjar, S.M. (2004). Spectroscopic and HPLC methods for the determination of alendronate in tablets and urine. Talanta. 64:695–702.
   PubMed Web of Science ®Google Scholar
• Andrade, S.F., Antoniolli, D., Comunello, E., Cardoso, L.G.V., Carvalho, J.C.T., Bastos, J.K. (2006). Antiulcerogenic activity of crude extract, fractions and populnoic acid isolated from Austroplenckia populnea (Celastraceae). Z Naturforsch C. 61:329–33.
   PubMed Web of Science ®Google Scholar
• Beck, R.C.R., Pohlmann, A.R., Benvenutti, E.V., Costa, T.D., Guterres, S.S. (2005). Nanostructure-coated diclofenac-loaded microparticles: preparation, morphological characterization, in vitro release and in vivo gastrointestinal tolerance. J Braz Chem Soc. 16:1233–40.
   Web of Science ®Google Scholar
• Blanco-Prieto, M.J., Campanero, M.A., Besseghir, K., Heimgatner, F., Gander, B. (2004). Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J Contr Rel. 96:437–48.
   PubMed Web of Science ®Google Scholar
• Cruz, L., Assumpção, E., Guterres, S.S., Pohlmann, A.R. (2009). High encapsulation efficiency of sodium alendronate in Eudragit S100/HPMC blend microparticles. Quim Nova. 32:1170–4.
   Web of Science ®Google Scholar
• Cruz, L., Schaffazick, S.R., Dalla Costa, T., Soares, L.U., Mezzalira, G., da Silveira, N.P., Schapoval, E.E.S., Pohlmann, A.R., Guterres, S.S. (2006a). Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity. J Nanosci Nanotechnol. 6:3154–62.
   PubMed Web of Science ®Google Scholar
• Cruz, L., Soares, L.U., Dalla Costa, T., Mezzalira, G., da Silveira, N.P., Guterres, S.S., Pohlmann, A.R. (2006b). Diffusion and mathematical modeling of release profiles from nanocarriers. Int J Pharm. 313:198–205.
   PubMed Web of Science ®Google Scholar
• Czuryszkiewicz, T., Areva, S., Honkanen, M., Linden, M. (2005). Synthesis of sol-gel silica materials providing a slow release of biphosphonate. Colloids Surf A Physicochem Eng Asp. 254:69–74.
   Web of Science ®Google Scholar
• De Groen, P.C., Lubbe, D.F., Hirsch, L.J., Daifotis, A., Stephenson, W., Freedholm, D., PryorTillotson, S., Seleznick, M.J., Pinkas, H., Wang, K.K. (1996). Esophagitis associated with the use of alendronate. N Engl J Med. 335:1016–21.
   PubMed Web of Science ®Google Scholar
• Ebetino, F.H., Roze, C.N., McKenna, C.E., Barnett, B.L., Dunford, J.E., Russell, R.G.G., Mieling, G.E., Rogers, M.J. (2005). Molecular interactions of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase. J Organomet Chem. 690:2679–87.
   Web of Science ®Google Scholar
• Freiberg, S., Zhu, X. (2004). Polymer microspheres for controlled drug release. Int J Pharm. 282:1–18.
   PubMed Web of Science ®Google Scholar
• Graham, D.Y., Malaty, H.M. (1999). Alendronate gastric ulcers. Aliment Pharmacol Ther. 13:515–9.
   PubMed Web of Science ®Google Scholar
• Guterres, S.S., Muller, C.R., Michalowski, C.B., Pohlmann, A.R., Dalla Costa, T. (2001). Gastro-intestinal tolerance following oral administration of spray-dried diclofenac-loaded nanocapsules and nanospheres. STP Pharma Sci. 11:229–33.
   Google Scholar
• Huang, W., Wang, Y., Ren, L., Du, C., Shi, X. (2009). A novel PHBV/HA microsphere releasing system loaded with alendronate. Mater Sci Eng C. 29:2221–5.
   Web of Science ®Google Scholar
• Korsmeyer, R.W., Gurny, R., Doelker, E., Buri, P., Peppas, N.A. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 15:25–35.
   Web of Science ®Google Scholar
• Kurkuri, M.D., Aminabhavi, T.M. (2004). Poly(vinyl alcohol) and poly(acrylic acid) sequential interpenetrating network pH-sensitive microspheres for the delivery of diclofenac sodium to the intestine. J Contr Rel. 96:9–20.
   PubMed Web of Science ®Google Scholar
• Lanza, F. (2003). Bisphosphonate mucosal injury—the end of the story? Dig Liver Dis. 35:67–70.
   PubMedGoogle Scholar
• Lanza, F., Schwartz, H., Sahba, B., Malaty, H.M., Musliner, T., Reyes, R., Quan, H., Graham, D.Y. (2000). An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae. Am J Gastroenterol. 95:3112–7.
   PubMed Web of Science ®Google Scholar
• Lavelle, E.C. (2001). Targeted delivery of drugs to the gastrointestinal tract. Crit Rev Ther Drug Carrier Syst. 18:341–86.
   PubMed Web of Science ®Google Scholar
• Li, W.W., Kendler, D.L. (2004). Pharmaceutical care and community pharmacists understanding of bisphosphonate dosing information. J Clin Pharm Ther. 29:531–6.
   PubMed Web of Science ®Google Scholar
• Lin, J.H. (1996). Bisphosphonates: a review of their pharmacokinetic properties. Bone. 18:75–85.
   PubMed Web of Science ®Google Scholar
• Lin, J.H., Chen, I.W., Deluna, F.A. (1994). Nonlinear kinetics of alendronate—plasma-protein binding and bone uptake. Drug Metab Dispos. 22:400–5.
   PubMed Web of Science ®Google Scholar
• Lionzo, M.I.Z., Re, M.I., Guterres, S.S., Pohlmann, A.R. (2007). Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly(epsilon-caprolactone) blends to control the release of a drug model. J Microencapsul. 24:175–86.
   PubMed Web of Science ®Google Scholar
• Luppi, B., Bigucci, F., Zecchi, V., Cerchiara, T. (2009). Gastroresistant microcapsules: new approaches for site-specific delivery of ketoprofen. Drug Deliv. 16:24–9.
   PubMed Web of Science ®Google Scholar
• Marshall, J.K., Thabane, M., James, C. (2006). Randomized active and placebo-controlled endoscopy study of a novel protected formulation of oral alendronate. Dig Dis Sci. 51:864–8.
   PubMed Web of Science ®Google Scholar
• Nafea, E.H., El-Massik, M.A., El-Khordagui, L.K., Marei, M.K., Khalafallah, M.N. (2007). Alendronate PLGA microspheres with high loading efficiency for dental applications. J Microencapsul. 24:525–38.
   PubMed Web of Science ®Google Scholar
• Palmieri, G.F., Michelini, S., Di Martino, P., Martelli, S. (2000). Polymers with pH-dependent solubility: possibility of use in the formulation of gastroresistant and controlled-release matrix tablets. Drug Dev Ind Pharm. 26:837–45.
   PubMed Web of Science ®Google Scholar
• Patashnik, S., Rabinovich, L., Golomb, G. (1997). Preparation and evaluation of chitosan microspheres containing bisphosphonates. J Drug Target. 4:371–80.
   PubMed Web of Science ®Google Scholar
• Peppas, N.A. (1985). Analysis of fickian and non-fickian drug release from polymers. Pharm Acta Helv. 60:110–1.
   PubMedGoogle Scholar
• Perez-Lopez, F.R. (2004). Postmenopausal osteoporosis and alendronate. Maturitas. 48:179–92.
   PubMed Web of Science ®Google Scholar
• Perugini, P., Genta, I., Conti, B., Modena, T., Pavanetto, F. (2001). Long-term release of clodronate from biodegradable microspheres. AAPS PharmSciTech. 2:1–10.
   Google Scholar
• Peter, C.P., Handt, L.K., Smith, S.M. (1998). Esophageal irritation due to alendronate sodium tablets—possible mechanisms. Dig Dis Sci. 43:1998–2002.
   PubMed Web of Science ®Google Scholar
• Poletto, F.S., Jager, E., Re, M.I., Guterres, S.S., Pohlmann, A.R. (2007). Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs. Int J Pharm. 345:70–80.
   PubMed Web of Science ®Google Scholar
• Raffin, R.P., Colome, L.M., Haas, S.E., Jornada, D.S., Pohlmann, A.R., Guterres, S.S. (2007). Development of HPMC and Eudragit S100 (R) blended microparticles containing sodium pantoprazole. Pharmazie. 62:361–4.
   PubMed Web of Science ®Google Scholar
• Raffin, R.P., Colome, L.M., Pohlmann, A.R., Guterres, S.S. (2006). Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. Eur J Pharm Biopharm. 63:198–204.
   PubMed Web of Science ®Google Scholar
• Raffin, R.P., Colome, L.M., Schapoval, E.E.S., Pohlmann, A.R., Guterres, S.S. (2008). Increasing sodium pantoprazole photostability by microencapsulation: effect of the polymer and the preparation technique. Eur J Pharm Biopharm. 69:1014–8.
   PubMed Web of Science ®Google Scholar
• Reginster, J.Y. (2006). Adherence and persistence: impact on outcomes and health care resources. Bone. 38:18–21.
   PubMed Web of Science ®Google Scholar
• Samdancioglu, S., Calis, S., Sumnu, M., Hincal, A.A. (2006). Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis. Drug Dev Ind Pharm. 32:473–81.
   PubMed Web of Science ®Google Scholar
• Sener, G., Goren, F.O., Ulusoy, N.B., Ersoy, Y., Arbak, S., Dulger, G.A. (2005). Protective effect of melatonin and omeprazole against alendronat-induced gastric damage. Dig Dis Sci. 50:1506–12.
   PubMed Web of Science ®Google Scholar
• Shi, X., Wang, Y., Ren, L., Gong, Y., Wang, D. (2009a). Enhancing alendronate release from a novel PLGA/Hydroxyapatite microspheric system for bone repairing applications. Pharm Res. 26:422–30.
   PubMed Web of Science ®Google Scholar
• Shi, X., Wang, Y., Varshney, R.R., Ren, L., Zhang, F., Wang, D. (2009b). In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite. Biomaterials. 30:3996–4005.
   PubMed Web of Science ®Google Scholar
• Siepmann, J., Peppas, N.A. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 48:139–57.
   PubMed Web of Science ®Google Scholar
• Varde, N.K., Pack, D.W. (2004). Microspheres for controlled release drug delivery. Expert Opin Biol Ther. 4:35–51.
   PubMed Web of Science ®Google Scholar
• Weidenauer, U., Bodmer, D., Kissel, T. (2003). Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part I: Evaluation of different techniques for the encapsulation of pamidronate di-sodium salt. J Microencapsul. 20:509–24.
   PubMed Web of Science ®Google Scholar
• Weidenauer, U., Bodmer, D., Kissel, T. (2004). Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part II: Implants allowing controlled drug release—a feasibility study using bisphosphonates. J Microencapsul. 21:137–49.
   PubMed Web of Science ®Google Scholar
• Yates, A.J., Rodan, G.A. (1998). Alendronate and osteoporosis. Drug Discov Today. 3:69–78.
   Web of Science ®Google Scholar